We are live on ! Find out more
EGI

EAM Global Investors Portfolio holdings

AUM $47.1M
1-Year Est. Return 320.45%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+320.45%
3 Year Est. Return
+2,492.23%
5 Year Est. Return
+19,933.92%
10 Year Est. Return
AUM
$205M
AUM Growth
-$29.7M
Cap. Flow
-$37.4M
Cap. Flow %
-18.21%
Top 10 Hldgs %
20.05%
Holding
168
New
44
Increased
17
Reduced
32
Closed
55

Top Sells

Rank Stock Value
1
GLIN icon
VanEck India Growth Leaders ETF
GLIN
+$4.44M
2
SE icon
Sea Limited
SE
+$3.57M
3
LIQT icon
LiqTech
LIQT
+$3.39M
4
CYBR
CyberArk
CYBR
+$2.93M
5
ARGX icon
argenx
ARGX
+$2.83M

Sector Composition

Rank Sector Weight
1 Technology 24.64%
2 Healthcare 22.5%
3 Industrials 15.41%
4 Consumer Discretionary 7.06%
5 Communication Services 7.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSB
76
DELISTED
GlobalSCAPE, Inc.
GSB
$1.45M 0.71%
+126,524
New +$1.47M
BCOV
77
DELISTED
Brightcove, Inc.
BCOV
$1.45M 0.71%
+138,289
New +$1.59M
KRYS icon
78
Krystal Biotech
KRYS
$9.66B
$1.44M 0.7%
41,329
+8,192
+25% +$366K
AVDR
79
DELISTED
Avedro, Inc Common Stock
AVDR
$1.43M 0.69%
62,794
-16,340
-21% -$355K
KOD icon
80
Kodiak Sciences
KOD
$2.84B
$1.41M 0.68%
+97,873
New +$1.28M
ARQL
81
DELISTED
Arqule Inc
ARQL
$1.39M 0.68%
194,454
FNKO icon
82
Funko
FNKO
$328M
$1.34M 0.65%
65,211
+8,153
+14% +$189K
ARWR icon
83
Arrowhead Research
ARWR
$12.4B
$1.33M 0.65%
47,186
-46,610
-50% -$1.38M
TNDM icon
84
Tandem Diabetes Care
TNDM
$1.56B
$1.31M 0.64%
22,145
-27,216
-55% -$1.74M
ARDX icon
85
Ardelyx
ARDX
$997M
$1.29M 0.63%
+274,679
New +$954K
VCYT icon
86
Veracyte
VCYT
$3.8B
$1.25M 0.61%
52,273
-46,310
-47% -$1.23M
ZYXI
87
DELISTED
Zynex
ZYXI
$1.25M 0.61%
144,731
LCI
88
DELISTED
Lannett Company, Inc.
LCI
$1.23M 0.6%
+27,405
New +$932K
GLDD
89
DELISTED
Great Lakes Dredge & Dock
GLDD
$1.21M 0.59%
116,002
-113,885
-50% -$1.2M
VSLR
90
DELISTED
VIVINT SOLAR, INC.
VSLR
$1.21M 0.59%
184,483
-25,379
-12% -$201K
AXSM icon
91
Axsome Therapeutics
AXSM
$10.9B
$1.19M 0.58%
58,622
-778
-1% -$20K
TVRD
92
Tvardi Therapeutics
TVRD
$23.4M
$1.17M 0.57%
+1,777
New +$1.48M
TPTX
93
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
$1.07M 0.52%
+28,441
New +$1.24M
NWPX icon
94
NWPX Infrastructure Inc
NWPX
$1.15B
$1.06M 0.52%
37,775
-12,210
-24% -$311K
CYRX icon
95
CryoPort
CYRX
$762M
$1.06M 0.52%
64,889
-15,130
-19% -$303K
ODT
96
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$1.06M 0.52%
+40,759
New +$1.36M
ACHN
97
DELISTED
Achillion Pharmaceuticals
ACHN
$1.03M 0.5%
+285,682
New +$1.1M
PAYS icon
98
Paysign
PAYS
$705M
$954K 0.46%
94,413
-70,297
-43% -$936K
RETA
99
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
$950K 0.46%
11,827
-10,030
-46% -$851K
BAND
100
Bandwidth Inc
BAND
$1.61B
$946K 0.46%
14,524
-6,262
-30% -$488K

Similar funds

EAM Global Investors's Q3 2019 Portfolio in Review

As of Q3 2019, EAM Global Investors held 168 positions worth $205M, down 13% from $235M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

EAM Global Investors withdrew a net $37.4M in Q3 2019, closing 55 positions and reducing 32 holdings. Its most notable exit was Sea Limited, an estimated $3.57M position sold in full.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

Against the trend, EAM Global Investors opened a new position in Fly Leasing Limited worth $5.78M.

  • EAM Global Investors's largest Q3 2019 buy was Fly Leasing Limited: 281,805 shares worth $5.78M.
  • EAM Global Investors added most to Perficient Inc in Q3 2019, an estimated $1.16M increase.
  • EAM Global Investors's biggest Q3 2019 reduction was VanEck India Growth Leaders ETF, cutting an estimated $4.44M.
  • EAM Global Investors fully exited Sea Limited in Q3 2019, selling an estimated $3.57M.
  • EAM Global Investors's ten largest holdings make up 20% of its $205M portfolio in Q3 2019.
  • EAM Global Investors opened 44 new positions and closed 55 in Q3 2019.
  • EAM Global Investors's portfolio value fell 13% quarter-over-quarter to $205M.

Based on EAM Global Investors's 13F filing for Q3 2019, filed 13 Nov 2019.